(Q52010578)

19 April 2018

title

Chronic symptoms are common in patients with neuroborreliosis -- a questionnaire follow-up study. (English)

1 reference

19 April 2018

0 references

1 reference

1 reference

Vrethem M

1

1 reference

19 April 2018

Hellblom L

2

1 reference

19 April 2018

Widlund M

3

1 reference

19 April 2018

Ahl M

4

1 reference

19 April 2018

Danielsson O

5

1 reference

19 April 2018

Ernerudh J

6

1 reference

19 April 2018

Forsberg P

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 October 2002

1 reference

19 April 2018

Acta Neurologica Scandinavica

published in

1 reference

19 April 2018

volume

106

1 reference

19 April 2018

issue

4

1 reference

19 April 2018

page(s)

205-208

1 reference

19 April 2018

Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi--specific immunoglobulin G, A, and M.

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

Asymptomatic Borrelia-seropositive individuals display the same incidence of Borrelia-specific interferon-gamma (IFN-gamma)-secreting cells in blood as patients with clinical Borrelia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

Chronic forms of Borrelia burgdorferi infection of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

Clinical and serologic follow-up in patients with neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

Clinical manifestations and diagnosis of neuroborreliosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

1 reference

7 January 2021

PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01358.X

7 January 2021

10.1034/J.1600-0404.2002.01358.X

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

12225315

1 reference

19 April 2018